There is insufficient evidence to claim that cerclage is the treatment of choice for patients with a cervical length <10 mm
- PMID: 29654737
- PMCID: PMC6105270
- DOI: 10.1016/j.ajog.2018.04.009
There is insufficient evidence to claim that cerclage is the treatment of choice for patients with a cervical length <10 mm
Conflict of interest statement
The authors report no conflict of interest
Comment on
-
Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.Am J Obstet Gynecol. 2018 Feb;218(2):161-180. doi: 10.1016/j.ajog.2017.11.576. Epub 2017 Nov 17. Am J Obstet Gynecol. 2018. PMID: 29157866 Free PMC article.
References
-
- Schünemann H, Brozek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendation. The GRADE Working Group; 2013.
-
- Klebanoff M 17 Alpha-hydroxyprogesterone caproate for preterm prevention: issues in subgroup analysis. Am J Obstet Gynecol 2016;214:306–7. - PubMed
-
- Berghella V, Ciardulli A, Rust OA, et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol 2017;50:569–77. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources